Roche Highlights Early Trial Success of Obesity Drug candidate

Roche announced that another drug candidate acquired from Carmot Therapeutics showed positive results in an early trial, establishing the Swiss company as a strong competitor in the obesity drug development race. They reported in a statement that...

Mabwell Receives China NMPA Nod To begin Phase II Trial

Mabwell, a cutting-edge biopharmaceutical company with full industry integration, revealed that its new Nectin-4 focused ADC (R&D code: 9MW2821) has been given the green light by the NMPA to move into phase II clinical testing as a standalone...

CordenPharma Commits €900M To Expand Peptide Technology Platform

CordenPharma, a partner for CDMO services for biotech and pharma companies developing complex modalities, has revealed its most significant strategic investment of approximately €900 million in the next three years to expand its peptide technology...

Mankind Pharma and Takeda Ink Pact To Market Vonoprazan in India

Mankind Pharma announced that it has signed a non-exclusive patent licensing deal with Takeda, a Japanese pharmaceutical company, to distribute Takeda's drug Vonoprazan in India. Mankind Pharma announced that it has signed a non-exclusive patent...

Serum Institute of India's Malaria Vaccine Introduced in Africa

A new "high efficacy" malaria vaccine co-created by the Serum Institute of India (SII) and the University of Oxford was formally carried out on Monday when Cote d'Ivoire in West Africa turned into the initial nation to commence regulating...

IMA Introduces Special Booklet on Headache Management

The IMA recently revealed a new booklet named 'Headache Algorithm: A guide to Headache Management' which focuses on managing headache disorders in India. This effort arrives at a critical moment as headache control is the primary reason for...

© 2024 India Pharma Outlook. All Rights Reserved.